| PHOTOGRAPH BY HANS PENNIK, AP PHOTO
| | By Victoria Jaggard, SCIENCE Executive Editor
There wasn’t much to do as a kid on the now-defunct Philadelphia Naval Shipyard. Base housing was pretty sparse, and the most fun to be had involved the few trees worth climbing. One activity was splashing barefoot through puddles in the stretch of concrete between us and the Delaware River. My mom nearly scared me half to death pulling me away, her shaky voice warning me of the dangers of contracting polio from the dirty water.
My parents were born before the invention of the first polio vaccine in the 1950s, and I was frolicking around before the World Health Organization formally launched its polio eradication campaign in the late 1980s. Today, two time-tested vaccines have brought polio in check, with just 33 new cases reported as of 2018, according to the WHO. All told, vaccines made my childhood safe from measles, mumps, tetanus, diphtheria, and a host of other ailments. So you can bet that when a proven vaccine finally comes ready for COVID-19, I will be there, sleeve rolled up in anticipation.
As of this writing, more than 150 candidate vaccines are in the pipeline, with seven already in the late stages of clinical trials. The drugs run the gamut from tried and true technologies that use a weakened virus to stimulate an immune response, to cutting-edge versions that use snippets of viral genes to do the job. (Pictured above, a volunteer gets an injection as part of a study for a possible vaccine.)
However, as Amy McKeever reports, vaccines take time to properly test and scale up. The fastest approved vaccine (for the mumps) took a whopping four years to go from inception to commercialization.
While today’s established vaccines are safe and effective, rushing out a new one is not without risks, points out Roxanne Khamsi. In the 1970s, a hastily developed flu vaccine caused 25 deaths, and medical experts today worry that pushing out a COVID-19 vaccine too soon could mean we settle for one with limited effectiveness at the cost of a better option down the road.
That’s not even getting into ethical questions about how much a vaccine will cost, which influences who can access it, and whether any vaccine for this virus will work for the elderly—the age group most at risk of dying from the disease. The rush to get a vaccine to market has even exacerbated problems with vaccine hesitancy, prompting many smart, well-educated people to say they would distrust a roll-out and avoid getting the shot. If the first vaccine we get does end up having problems, that will only make matters worse.
I’m as eager as anyone else to put COVID-19 in the rear-view mirror and start the hard work of building our post-pandemic future. But I’ve found that when driving (and editing), speed causes accidents, so I hope scientists will take the time to get this one right, for all our sakes.
Do you get this daily? If not, sign up here or forward to a friend. | | | |
0 comments:
Post a Comment